Ampio Pharmaceuticals
AMPE
#10613
Rank
โ‚ฌ0 M
Marketcap
0,004466ย โ‚ฌ
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Ampio Pharmaceuticals (AMPE)

EPS in 2023 (TTM): -16,58ย โ‚ฌ

According to Ampio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -14,64ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -18,62ย โ‚ฌ an increase over its 2021 EPS that were of -23,19ย โ‚ฌ.

EPS history for Ampio Pharmaceuticals from 2006 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-16,58ย โ‚ฌ-10.97%
2022-18,62ย โ‚ฌ-19.7%
2021-23,19ย โ‚ฌ-0%
2020-23,19ย โ‚ฌ-10%
2019-25,77ย โ‚ฌ-121.74%
2018118,53ย โ‚ฌ-158.23%
2017-203,56ย โ‚ฌ119.44%
2016-92,76ย โ‚ฌ-41.94%
2015-159,76ย โ‚ฌ-18.42%
2014-195,83ย โ‚ฌ20.63%
2013-162,33ย โ‚ฌ85.29%
2012-87,61ย โ‚ฌ-52.11%
2011-182,95ย โ‚ฌ44.9%
2010-126,26ย โ‚ฌ390%
2009-25,77ย โ‚ฌ233.33%
2008-7,73ย โ‚ฌ-0%
2007-7,73ย โ‚ฌ
2006N/A

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Aerie Pharmaceuticals
AERI
-0,64ย โ‚ฌ-95.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
8,97ย โ‚ฌ-161.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Rigel Pharmaceuticals
RIGL
5,44ย โ‚ฌ-137.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
6,92ย โ‚ฌ-147.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
37,31ย โ‚ฌ-354.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1,48ย โ‚ฌ-110.09%๐Ÿ‡บ๐Ÿ‡ธ USA